May 02, 2023 / 06:30PM GMT
Doug Tsao - H.C. Wainwright & Co. LLC - Senior Analyst
Welcome, everybody. I'm Doug Tsao, senior analyst at H.C. Wainwright. We are thrilled to have our next session with Disc Medicine, represented by John Quisel.
John Quisel - Disc Medicines, Inc. - CEO
Quisel.
Questions and Answers:
Doug Tsao - H.C. Wainwright & Co. LLC - Senior AnalystQuisel. Sorry. My apologies. So we'll sort of jump into it. So you're a relatively new company to the public markets after your merger with Gemini Therapeutics. So maybe provide a quick overview of the company, what it was founded, and your vision, and what you're trying to accomplish.
John Quisel - Disc Medicines, Inc. - CEO
Yes, thanks. Great to be here today. Appreciate the time. So, Disc Medicine, we went public through a reverse merger with Gemini Therapeutics just at the end of last year. So we've been public now for a few months. Our vision is to build a great hematology company. We think this is a fantastic area for
Trustpilot
